BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20148873)

  • 41. Oligodendroglial abnormalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or molecular phenocopies?
    Sokolov BP
    Int J Neuropsychopharmacol; 2007 Aug; 10(4):547-55. PubMed ID: 17291372
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The incoherence hypothesis of schizophrenia: based on decomposed oligodendrocyte-axonic relations.
    Mitterauer B
    Med Hypotheses; 2007; 69(6):1299-304. PubMed ID: 17502129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Network analysis of positional candidate genes of schizophrenia highlights myelin-related pathways.
    Rietkerk T; Boks MP; Sommer IE; de Jong S; Kahn RS; Ophoff RA
    Mol Psychiatry; 2009 Apr; 14(4):353-5. PubMed ID: 19308022
    [No Abstract]   [Full Text] [Related]  

  • 44. RNA on the road to myelin.
    Barbarese E; Brumwell C; Kwon S; Cui H; Carson JH
    J Neurocytol; 1999; 28(4-5):263-70. PubMed ID: 10739569
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intracellular messengers. Influence of oligodendrocyte substratum adhesion.
    Vartanian T; Dawson G; Szuchet S
    Ann N Y Acad Sci; 1988; 540():433-6. PubMed ID: 2462818
    [No Abstract]   [Full Text] [Related]  

  • 46. Numerical density of oligodendrocytes and oligodendrocyte clusters in the anterior putamen in major psychiatric disorders.
    Kolomeets NS; Uranova NA
    Eur Arch Psychiatry Clin Neurosci; 2020 Oct; 270(7):841-850. PubMed ID: 32060609
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduced 2',3'-cyclic nucleotide 3'-phosphohydrolase activity in erythrocyte membranes of patients with multiple sclerosis.
    Dreiling CE; Norrgran C; Smith E
    Metab Pediatr Syst Ophthalmol (1985); 1985; 8(2-3):69-74. PubMed ID: 2836692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effects of Codonopsis pilosular-Astragalus injection on the cyclic nucleotide levels and phosphodiesterase activity in platelets].
    Chai ZN
    Zhong Xi Yi Jie He Za Zhi; 1984 Aug; 4(8):486-7. PubMed ID: 6094033
    [No Abstract]   [Full Text] [Related]  

  • 49. Myelinated nerves: filling in the juxtaparanodal gap.
    Brophy PJ
    Curr Biol; 2003 Dec; 13(24):R956-7. PubMed ID: 14680652
    [No Abstract]   [Full Text] [Related]  

  • 50. Change in the expression of myelination/oligodendrocyte-related genes during puberty in the rat brain.
    Matsuoka T; Sumiyoshi T; Tsunoda M; Takasaki I; Tabuchi Y; Uehara T; Itoh H; Suzuki M; Kurachi M
    J Neural Transm (Vienna); 2010 Nov; 117(11):1265-8. PubMed ID: 20798964
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A possible link between dopamine action and myelin dysfunction in schizophrenia.
    Lindholm E; Jazin E
    Schizophr Res; 2007 Nov; 96(1-3):271-2. PubMed ID: 17761402
    [No Abstract]   [Full Text] [Related]  

  • 52. Network analysis of positional candidate genes of schizophrenia highlights...more than... myelin-related pathways.
    Guilloux JP; Gaiteri C; Sibille E
    Mol Psychiatry; 2010 Aug; 15(8):786-8. PubMed ID: 20351722
    [No Abstract]   [Full Text] [Related]  

  • 53. Human blood analysis reveals differences in gene expression of catecholamine-regulated protein 40 (CRP40) in schizophrenia.
    Groleau SE; Lubarda J; Thomas N; Ferro MA; Pristupa ZB; Mishra RK; Gabriele JP
    Schizophr Res; 2013 Jan; 143(1):203-6. PubMed ID: 23182727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MYRF: A Mysterious Membrane-Bound Transcription Factor Involved in Myelin Development and Human Diseases.
    Huang H; Zhou F; Zhou S; Qiu M
    Neurosci Bull; 2021 Jun; 37(6):881-884. PubMed ID: 33864620
    [No Abstract]   [Full Text] [Related]  

  • 55. Oligodendrocyte density is changed in the basolateral amygdala in schizophrenia but not depression.
    Williams MR; Harb H; Pearce RK; Hirsch SR; Maier M
    Schizophr Res; 2013 Jul; 147(2-3):402-3. PubMed ID: 23639671
    [No Abstract]   [Full Text] [Related]  

  • 56. New insights into altered gene regulation in schizophrenia.
    Wood H
    Nat Rev Neurol; 2019 Nov; 15(11):619. PubMed ID: 31548651
    [No Abstract]   [Full Text] [Related]  

  • 57. Evaluating Gene Expression and Methylation Profiles of TCF4, MBP, and EGR1 in Peripheral Blood of Drug-Free Patients with Schizophrenia: Correlations with Psychopathology, Intelligence, and Cognitive Impairment.
    Yazarlou F; Tabibian M; Azarnezhad A; Sadeghi Rad H; Lipovich L; Sanati G; Mostafavi Abdolmaleky H; Alizadeh F
    J Mol Neurosci; 2023 Oct; 73(9-10):738-750. PubMed ID: 37668894
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gene expression alterations related to mania and psychosis in peripheral blood of patients with a first episode of psychosis.
    Gouvea ES; Ota VK; Noto C; Santoro ML; Spindola LM; Moretti PN; Carvalho CM; Xavier G; Rios AC; Sato JR; Hayashi MA; Brietzke E; Gadelha A; Bressan RA; Cordeiro Q; Belangero SI
    Transl Psychiatry; 2016 Oct; 6(10):e908. PubMed ID: 27701407
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Coding and noncoding gene expression biomarkers in mood disorders and schizophrenia.
    Mamdani F; Martin MV; Lencz T; Rollins B; Robinson DG; Moon EA; Malhotra AK; Vawter MP
    Dis Markers; 2013; 35(1):11-21. PubMed ID: 24167345
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Utilization of never-medicated bipolar disorder patients towards development and validation of a peripheral biomarker profile.
    Clelland CL; Read LL; Panek LJ; Nadrich RH; Bancroft C; Clelland JD
    PLoS One; 2013; 8(6):e69082. PubMed ID: 23826396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.